======= TRIM37 ======= == Gene Information == * **Official Symbol**: TRIM37 * **Official Name**: tripartite motif containing 37 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4591|4591]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94972|O94972]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRIM37&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRIM37|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605073|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the tripartite motif (TRIM) family, whose members are involved in diverse cellular functions such as developmental patterning and oncogenesis. The TRIM motif includes zinc-binding domains, a RING finger region, a B-box motif and a coiled-coil domain. The RING finger and B-box domains chelate zinc and might be involved in protein-protein and/or protein-nucleic acid interactions. The gene mutations are associated with mulibrey (muscle-liver-brain-eye) nanism, an autosomal recessive disorder that involves several tissues of mesodermal origin. [provided by RefSeq, Mar 2016]. COMPLETENESS: complete on the 3' end. * **UniProt Summary**: E3 ubiquitin-protein ligase required to prevent centriole reduplication (PubMed:15885686, PubMed:23769972). Probably acts by ubiquitinating positive regulators of centriole reduplication (PubMed:23769972). Mediates monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub), a specific tag for epigenetic transcriptional repression: associates with some Polycomb group (PcG) multiprotein PRC2-like complex and mediates repression of target genes (PubMed:25470042). Has anti-HIV activity (PubMed:24317724). {ECO:0000269|PubMed:15885686, ECO:0000269|PubMed:23769972, ECO:0000269|PubMed:24317724, ECO:0000269|PubMed:25470042}. |zf-B box| |aggresome assembly| |inclusion body assembly| |negative regulation of centriole replication| |histone H2A-K119 monoubiquitination| |negative regulation of centrosome duplication| |negative regulation of centrosome cycle| |ESC/E(Z) complex| |histone H2A monoubiquitination| |regulation of centriole replication| |histone H2A ubiquitination| |histone monoubiquitination| |tumor necrosis factor receptor binding| |negative regulation of organelle assembly| |histone ubiquitination| |aggresome| |regulation of centrosome duplication| |regulation of centrosome cycle| |protein monoubiquitination| |protein autoubiquitination| |negative regulation of NF-kappaB transcription factor activity| |peroxisome| |negative regulation of cytoskeleton organization| |positive regulation of NF-kappaB transcription factor activity| |negative regulation of DNA-binding transcription factor activity| |regulation of microtubule cytoskeleton organization| |regulation of organelle assembly| |ubiquitin protein ligase activity| |regulation of microtubule-based process| |ubiquitin-protein transferase activity| |positive regulation of DNA-binding transcription factor activity| |ubiquitin protein ligase binding| |negative regulation of cell cycle process| |histone modification| |negative regulation of organelle organization| |covalent chromatin modification| |chromatin binding| |regulation of DNA-binding transcription factor activity| |regulation of cytoskeleton organization| |negative regulation of cell cycle| |protein ubiquitination| |perinuclear region of cytoplasm| |chromatin organization| |negative regulation of cellular component organization| |regulation of cell cycle process| |protein modification by small protein conjugation| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |regulation of cellular component biogenesis| |protein modification by small protein conjugation or removal| |chromosome organization| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| |positive regulation of molecular function| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|1.73| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.77| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.87| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|1.9| |[[:results:exp150|SGC0649 7μM R03 exp150]]|1.95| |[[:results:exp480|ETC-159 50μM R08 exp480]]|2| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|2.02| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.27| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|2/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6905 * **Expression level (log2 read counts)**: 6.62 {{:chemogenomics:nalm6 dist.png?nolink |}}